CAPA & Q10

Conducted by: Ms. Karen Ginsbury
SKU: 22137
Print version

Share a colleague:

Corrective and Preventive Action (CAPA), is a “well-known pharmaceutical concept” according to FDA’s quality systems guidance (2006). Actually the concept, while well-known in the medical device industry and through ISO certification systems, has been notably missed in pharmaceutical GMPs to-date.  The recently issued ICH Q10 guidance, addresses four specific pharmaceutical quality system elements that augment GMPs to achieve the objectives of...Continue reading

Corrective and Preventive Action (CAPA), is a “well-known pharmaceutical concept” according to FDA’s quality systems guidance (2006). Actually the concept, while well-known in the medical device industry and through ISO certification systems, has been notably missed in pharmaceutical GMPs to-date.  The recently issued ICH Q10 guidance, addresses four specific pharmaceutical quality system elements that augment GMPs to achieve the objectives of a modern, successful and effective quality system.
This course will look at what CAPA really is, how information is gathered and fed into the system and how issues are investigated to address root cause and resolve the issue, preventing recurrence.
This course will help your company develop an escalation policy (addressed in Q10) to take unresolved items through the management hierarchy to ensure resolution.

Close
Dates: 
  • 19/01/2022
  • 26/01/2022
Course location: Zoom Course
Duration: 1-Day Course
Hours: 10:00 - 13:30
Credits: 1
Course Language: עברית

Course price: ₪1,800 + VAT
Early registration is Closed
Do you have a subscription? You deserve more

Have a question? We got all the answers

Issues to be covered

  • CAPA and its roots in ISO
  • ICH Q10 – Pharmaceutical Quality System: the need for enhancing GMP with a global guidance
  • CAPA = 25% of a quality system
  • What constitutes a deviation or identified deficiency in a quality system
  • Corrective Action
  • Preventive Action
  • Investigations:
    • when are they NOT needed
    • how to conduct an investigation
    • how to document an investigation
    • conclusions as opposed to findings (facts)
  • Managing a CAPA system: manual vs computerized (part 11 compliance?)
  • Escalation process (SOP) for resolving tough issues

Who should attend

VP Operations, Production Managers, Quality Unit Directors, VP Quality, VP QA / RA, Quality Unit Supervisors, RA personnel, personnel involved in product development, Operations and Production personnel and Supervisors, Laboratory personnel and any other person involved directly or indirectly in compliance and quality related activities.

Benefits to the Participants

  • Understanding how a CAPA system forms one of the four pillars of a quality system and how to conduct effective investigations of defects and deficiencies in the quality system.
  • A clear understanding of the difference between corrective as opposed to preventive actions will be achieved.

About The Lecturer

Karen Ginsbury
B.Pharm, M.Sc, MRPharmS, has over twenty years of experience in
Read more

Leave a Reply

    [anr_nocaptcha g-recaptcha-response]